Stock Earnings

Question 1

BioSyent Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、BioSyent Incの総資産は$41で、純profitは$7です。

Question 2

BIOYFの主要な財務比率は何ですか？

Accepted Answer

BioSyent Incの流動比率は6.83、純利益率は20、1株当たり売上高は$2.96です。

Question 3

BioSyent Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

BioSyent Inc largest revenue segment is Pharmaceutical, at a revenue of 30,602,646 in the most earnings release.For geography, Canada is the primary market for BioSyent Inc, at a revenue of 30,300,745.

Question 4

BioSyent Incは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、BioSyent Incの純profitは$7です。

Question 5

BioSyent Incに負債はありますか？

Accepted Answer

yes、BioSyent Incの負債は6です。

Question 6

BioSyent Incの発行済株式数は何株ですか？

Accepted Answer

BioSyent Incの総発行済株式数は11.28株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	39	35	31	27	28	22
Revenue Growth (YoY)	18%	13%	15%	-4%	27%	5%
Cost of Revenue	8	7	5	5	5	4
Gross Profit	30	27	25	22	22	17
Selling, General & Admin	19	18	17	15	13	11
Research & Development	0	0	0	0	0	0
Operating Expenses	20	18	18	15	14	12
Other Non Operating Income (Expenses)	--	--	--	0	0	--
Pretax Income	11	9	8	7	8	5
Income Tax Expense	2	2	2	1	2	1
Net Income	8	7	6	5	6	3
Net Income Growth	14%	17%	20%	-17%	100%	-25%
Shares Outstanding (Diluted)	11.49	11.8	12.17	12.54	12.87	13.09
Shares Change (YoY)	-3%	-3%	-3%	-3%	-2%	-6%
EPS (Diluted)	0.71	0.61	0.53	0.43	0.48	0.28
EPS Growth	19%	16%	22%	-11%	68%	-7%
Free Cash Flow	11	8	4	4	4	6
Free Cash Flow Per Share	0.95	0.67	0.32	0.31	0.31	0.45
Gross Margin	76.92%	77.14%	80.64%	81.48%	78.57%	77.27%
Operating Margin	25.64%	25.71%	22.58%	25.92%	28.57%	22.72%
Profit Margin	20.51%	20%	19.35%	18.51%	21.42%	13.63%
Free Cash Flow Margin	28.2%	22.85%	12.9%	14.81%	14.28%	27.27%
EBITDA	10	9	7	7	8	5
EBITDA Margin	25.64%	25.71%	22.58%	25.92%	28.57%	22.72%
D&A For EBITDA	0	0	0	0	0	0
EBIT	10	9	7	7	8	5
EBIT Margin	25.64%	25.71%	22.58%	25.92%	28.57%	22.72%
Effective Tax Rate	18.18%	22.22%	25%	14.28%	25%	20%

BioSyent Inc (BIOYF) Price

BIOYF Stock Price Chart

BIOYF Income

Follow-Up Questions